Inspire Medical Systems (INSP) EBIT Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Inspire Medical Systems | 1.17 Bn | 889.44 Mn | 176.91 Mn | 24.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.71% |
| Dec 31, 2025 | 44.62% |
| Sep 30, 2025 | -32.64% |
| Jun 30, 2025 | -165.03% |
| Mar 31, 2025 | 90.24% |
| Dec 31, 2024 | 242.95% |
| Sep 30, 2024 | 206.29% |
| Jun 30, 2024 | 130.72% |
| Mar 31, 2024 | 21.95% |
| Dec 31, 2023 | 2,875.22% |
| Sep 30, 2023 | 21.65% |
| Jun 30, 2023 | -18.51% |
| Mar 31, 2023 | -21.44% |
| Dec 31, 2022 | 81.60% |
| Sep 30, 2022 | -75.52% |
| Jun 30, 2022 | -11.66% |
| Mar 31, 2022 | -2.34% |
| Dec 31, 2021 | 74.21% |
| Sep 30, 2021 | 0.97% |
| Jun 30, 2021 | 45.02% |
| Mar 31, 2021 | 4.57% |
| Dec 31, 2020 | 24.01% |
| Sep 30, 2020 | -14.35% |
| Jun 30, 2020 | -179.04% |
| Mar 31, 2020 | -87.31% |
| Dec 31, 2019 | -89.77% |
| Sep 30, 2019 | -86.08% |
| Jun 30, 2019 | -45.04% |
| Mar 31, 2019 | -68.95% |
| Dec 31, 2018 | -27.33% |
| Sep 30, 2018 | -27.40% |
| Jun 30, 2018 | -28.58% |
| Mar 31, 2018 | -25.97% |